Renal denervation in human hypertension: mechanisms, current findings, and future prospects (Q37997998)

26 August 2017

Renal denervation in human hypertension: mechanisms, current findings, and future prospects (English)

1 reference

26 August 2017

arterial hypertension

0 references

4

Henry Krum

1 reference

26 August 2017

2

Dagmara Hering

1 reference

26 August 2017

Markus P Schlaich

1

1 reference

PubMed ID

22457244

26 August 2017

Paul A Sobotka

series ordinal

3

1 reference

PubMed ID

22457244

26 August 2017

Murray D Esler

series ordinal

5

1 reference

26 August 2017

1 June 2012

1 reference

Current Hypertension Reports

26 August 2017

1 reference

26 August 2017

14

1 reference

26 August 2017

3

1 reference

26 August 2017

247-253

1 reference

https://scigraph.springernature.com/pub.10.1007/s11906-012-0264-9

26 August 2017

0 references

cites work

Effect of renal sympathetic nerve stimulation on proximal water and sodium reabsorption

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0264-9

Sympathetic modulation of renal hemodynamics, renin release and sodium excretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0264-9

A limited renal injury may cause a permanent form of neurogenic hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0264-9

Renal injury caused by intrarenal injection of phenol increases afferent and efferent renal sympathetic nerve activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0264-9

Renal afferent denervation prevents hypertension in rats with chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0264-9

Renal afferent denervation prevents the progression of renal disease in the renal ablation model of chronic renal failure in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0264-9

Sympathetic nervous system and the kidney in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0264-9

Neural control of the kidney: past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0264-9

Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and Angiotensin neuromodulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0264-9

Regional sympathetic effects of low-dose clonidine in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0264-9

Long-term outcome in relation to renal sympathetic activity in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0264-9

Renal denervation abolishes hypertension in low-birth-weight offspring from pregnant rats with reduced uterine perfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0264-9

Sympathectomy in the treatment of hypertension; review of 122 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0264-9

Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0264-9

Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0264-9

Renal sympathetic-nerve ablation for uncontrolled hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0264-9

Evidence against reinnervation of cardiac vagal afferents after human orthotopic cardiac transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0264-9

Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0264-9

Sympathetic nervous activation in obesity and the metabolic syndrome--causes, consequences and therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0264-9

The effects of weight loss versus weight loss maintenance on sympathetic nervous system activity and metabolic syndrome components.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0264-9

Renal denervation as a therapeutic approach for hypertension: novel implications for an old concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0264-9

Sympathetic activation in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0264-9

Exercise augments weight loss induced improvement in renal function in obese metabolic syndrome individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0264-9

Reflex sympathetic activation induces acute insulin resistance in the human forearm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0264-9

Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0264-9

Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0264-9

Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0264-9

Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0264-9

Body weight reduction, sympathetic nerve traffic, and arterial baroreflex in obese normotensive humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0264-9

Baroreflex control of sympathetic nerve activity and heart rate in obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0264-9

Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0264-9

Moxonidine treatment of hypertensive patients with advanced renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0264-9

Blood pressure regulation in end-stage renal disease and anephric man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0264-9

Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0264-9

Renal denervation in moderate to severe CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0264-9

Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0264-9

Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure

21 January 2018

1 reference

12 December 2020

Noradrenaline release and the pathophysiology of primary human hypertension

1 reference

12 December 2020

Poor long-term survival after acute myocardial infarction among patients on long-term dialysis

1 reference

12 December 2020

Preeclampsia -- a state of sympathetic overactivity

1 reference

12 December 2020

Neurohumoral, hemodynamic and microvascular changes as mechanisms of insulin resistance in hypertension: a provocative but partial picture

1 reference

12 December 2020

Blood pressure and end-stage renal disease in men

1 reference

12 December 2020

Neural control of renal circulation

1 reference

12 December 2020

Functional reinnervation and development of supersensitivity to NE after renal denervation in rats

1 reference

12 December 2020

Neurogenic factors and hypertension in chronic renal failure

1 reference

12 December 2020

Regression of left ventricular hypertrophy after bilateral nephrectomy

1 reference

12 December 2020

Renal denervation attenuates the sodium retention and hypertension associated with obesity

1 reference

12 December 2020

The sympathetic nervous system and hypertension: recent developments

1 reference

12 December 2020

Neural control of renal function

1 reference

12 December 2020

Passage of glucose through the cell membrane of capillary endothelium

1 reference

12 December 2020

Baseline sympathetic nervous system activity predicts dietary weight loss in obese metabolic syndrome subjects

1 reference

12 December 2020

Lowering of microalbuminuria in diabetic patients by a sympathicoplegic agent: novel approach to prevent progression of diabetic nephropathy?

1 reference

12 December 2020

Innervation of the renal cortex

1 reference

12 December 2020

Cardiovascular complications in renal failure

1 reference

12 December 2020

Neurogenic factors and hypertension in renal disease.

1 reference

12 December 2020

Neural regulation of renin release: experimental evidence and clinical implications in arterial hypertension

1 reference

12 December 2020

Hypertension in chronic renal failure. Treatment with hemodialysis and nephrectomy

1 reference

12 December 2020

Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity

1 reference

12 December 2020

Mechanism of elevated plasma noradrenaline in the course of essential hypertension

1 reference

12 December 2020

Splanchnicectomy for essential hypertension; results in 1,266 cases

1 reference

12 December 2020

10.1007/S11906-012-0264-9

Identifiers

DOI

1 reference

26 August 2017

1 reference

PubMed ID

22457244